| Sequential variceal pressure measurement by endoscopic needle puncture during maintenance sclerotherapy: the correlation between variceal pressure and variceal rebleeding. | |
| | |
MedLine Citation:
|
PMID: 9833915 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND/AIMS: The risk factors for esophageal variceal rebleeding are little known. Variceal pressure is one of the major determinants of variceal rupture, but the relationship between variceal pressure and variceal rebleeding during maintenance sclerotherapy has not been determined. This study was undertaken to evaluate the relationship between variceal pressure/gradient change and variceal rebleeding during maintenance sclerotherapy. METHODS: Patients with liver cirrhosis and recent esophageal variceal hemorrhage underwent consecutive variceal pressure measurements by direct puncture of the varices before each elective sclerotherapy. RESULTS: In 46 patients, the initial variceal pressure was no different regardless of age, sex, underlying etiology or hepatic reserve. Variceal pressure was higher in large varices, varices with more severe red wale markings, and varices with slower reduction in size during maintenance sclerotherapy. A larger volume of sclerosant was required to eradicate large varices, varices with more severe red wale markings, and varices with slower reduction in size during maintenance sclerotherapy. There was a positive correlation between initial variceal pressure and total amount of sclerosant (r=0.485, p=0.001). Initial variceal pressure was not related to rebleeding. Variceal pressure increased more in patients with rebleeding from varices per se (n=7) than in those without rebleeding (n= 24). There was no difference in pressure change between patients without rebleeding (n=24) and those with rebleeding from variceal ulcers (n=7). CONCLUSIONS: Large varices, severe red color signs and slow reduction in variceal size were associated with higher initial variceal pressure, and more sclerosant was required to eradicate the varices. An increase in variceal pressure during maintenance sclerotherapy indicates a higher risk of variceal rebleeding, but not of variceal ulcer rebleeding. |
| | |
Authors:
|
M C Hou; H C Lin; B I Kuo; T M Liao; F Y Lee; F Y Chang; S D Lee |
Related Documents
:
|
3485345 - "congestion index" of the portal vein. 15447755 - Acute administration of carvedilol is more effective than propranolol plus isosorbide-5... 8627885 - Forskolin: a promising new adjunct to intracavernous pharmacotherapy. 3130825 - Variceal bleeding, hypersplenism, and systemic mastocytosis. pathophysiology and manage... 9101505 - Metabolic correlates of obesity and radiographic features of knee osteoarthritis: data ... 18845775 - Individualization of transfer function in estimation of central aortic pressure from th... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of hepatology Volume: 29 ISSN: 0168-8278 ISO Abbreviation: J. Hepatol. Publication Date: 1998 Nov |
Date Detail:
|
Created Date: 1999-02-10 Completed Date: 1999-02-10 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8503886 Medline TA: J Hepatol Country: DENMARK |
Other Details:
|
Languages: eng Pagination: 772-8 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Veterans General Hospital-Taipei and National Yang-Ming University School of Medicine, Taiwan, Republic of China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Esophageal and Gastric Varices / physiopathology* Esophagoscopes Esophagoscopy / adverse effects Female Gastrointestinal Hemorrhage / etiology*, physiopathology, therapy* Humans Liver Cirrhosis / complications*, physiopathology Male Middle Aged Punctures Sclerotherapy / adverse effects*, instrumentation, methods |
| Comments/Corrections | |
Comment In:
|
J Hepatol. 1998 Nov;29(5):829-31
[PMID:
9833924
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats.
Next Document: Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early...